Misfolding of Amyloid-beta and tau in Alzheimer’s and Other Neurodegenerative Diseases
Autor Louise Serpellen Limba Engleză Hardback – 31 dec 2024
- Focuses on structural biology and the cellular effects leading to Alzheimer’s and other neurodegenerative diseases
- Answers the question, how do Amyloid beta and tau influence one another?
- Discusses the Kinetics, conformational change, role of sequence, and mutations of Amyloid-beta and tau
Preț: 672.55 lei
Preț vechi: 739.06 lei
-9% Nou
Puncte Express: 1009
Preț estimativ în valută:
128.70€ • 133.56$ • 107.58£
128.70€ • 133.56$ • 107.58£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323992688
ISBN-10: 0323992684
Pagini: 300
Dimensiuni: 151 x 229 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0323992684
Pagini: 300
Dimensiuni: 151 x 229 mm
Editura: ELSEVIER SCIENCE
Cuprins
1. Historical perspective: introduction to the discovery of pathological proteins deposited in Alzheimer’s disease
2. Genetics of Alzheimer’s disease and the generation of Amyloid beta
3. Genetics of tauopathies
4. Self-assembly of Amyloid-beta and tau (Kinetics, conformational change, role of sequence, mutations)
5. Structure of amyloid fibrils formed by Amyloid-beta and tau: latest perspectives from CryoEM and what has led up to its contribution
6. The role of amyloid beta and tau in disease: how might oligomers and fibrils affect neuronal health and physiological health in humans
7. Therapeutics that target amyloid beta and tau generation and aggregation
8. Diagnostics: using the deposition and conformational status of Amyloid beta and tau for diagnosis (MRI; CSF analysis and Prion seeding assays)
9. Interaction: how do Amyloid beta and tau influence one another?
10. Other proteins: the contribution of ApoE genotype to amyloid and tau aggregation and clearance
11. Other proteins: The role of chaperone system in disease: proteostasis and disease
12. Future perspectives: what the future holds and where will research go next?
2. Genetics of Alzheimer’s disease and the generation of Amyloid beta
3. Genetics of tauopathies
4. Self-assembly of Amyloid-beta and tau (Kinetics, conformational change, role of sequence, mutations)
5. Structure of amyloid fibrils formed by Amyloid-beta and tau: latest perspectives from CryoEM and what has led up to its contribution
6. The role of amyloid beta and tau in disease: how might oligomers and fibrils affect neuronal health and physiological health in humans
7. Therapeutics that target amyloid beta and tau generation and aggregation
8. Diagnostics: using the deposition and conformational status of Amyloid beta and tau for diagnosis (MRI; CSF analysis and Prion seeding assays)
9. Interaction: how do Amyloid beta and tau influence one another?
10. Other proteins: the contribution of ApoE genotype to amyloid and tau aggregation and clearance
11. Other proteins: The role of chaperone system in disease: proteostasis and disease
12. Future perspectives: what the future holds and where will research go next?